Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Revenue and income slide as Allied Minds exits mature investments

Thu, 26th Sep 2019 12:42

(Sharecast News) - Intellectual property commercialisation company Allied Minds reported a fall in first-half net cash and investments to $56.8m (£45.04m) on Thursday, from $97.7m year-on-year, of which it said $46.6m was held at the parent level, compared to $50.6m.
The London-listed firm said that reflected its investment in portfolio companies and headquarters operating expenses, offset by cash inflows from the sale or dissolution of Allied-Bristol Life Sciences, Percipient Networks and Signature Medical.

Revenue slid to $1.5m for the six months ended 30 June, from $2.1m a year earlier, which the board put down to the "early stage nature" of its portfolio companies, and the deconsolidation of two of its existing portfolio companies - HawkEye 360 and Spin Memory - in the second half of 2018.

Income for the period stood at $2.5m, falling from $4.3m, of which $3.1m was attributable to the company, swinging from an attributable loss of $12.5m year-on-year.

Allied Minds said that primarily reflected sales, general and administrative expenses and research and development spending of $16.4m and $12.3m respectively, to support portfolio company development activities.

It also reportedly reflected other income of $24.7m, from a $33.9m in gain on investments held at fair value offset by the company's share of losses of $9.2m from the deconsolidated entities accounted for under the equity method.

Allied Minds said it had invested $24.3m into its portfolio companies so far in 2019, including $15.3m post-period end, adding that third-party investors subscribed for $110.3m of portfolio company equity during the year to date, including $105.8m since the period ended.

"We have made good progress since our appointment to implement our revised strategy of focusing exclusively on supporting our existing portfolio companies and maximising monetisation opportunities at the right time, while reducing ongoing annualised HQ operating expenses," said co-chief executive officers Joseph Pignato and Michael Turner in a joint statement.

"The strong funding rounds at HawkEye 360 and Federated Wireless, together with the significant technical and commercial progress throughout the technology portfolio, demonstrate the value and momentum of the portfolio."

Pignato and Turner said the announced sale of the company's HawkEye 360 shares was a "major" development.

"The sale provides an excellent return on invested capital, enables us to make a significant return of cash to shareholders, and strengthens our ability to continue to fund and support our existing technology portfolio."
More News
25 Apr 2016 11:00

LONDON MARKET MIDDAY: Resource Stocks Drag FTSE As Brent Rally Stalls

Read more
25 Apr 2016 10:18

EXTRA: Allied Minds Annual Loss Widens As It Invests In New Businesses

Read more
25 Apr 2016 09:38

WINNERS & LOSERS SUMMARY: St Ives Dives After Profit Warning

Read more
25 Apr 2016 07:36

LONDON MARKET OPEN: Mixed Trade As Miners And Drillers Drag FTSE 100

Read more
25 Apr 2016 07:19

Allied Minds losses widen as group ramps up invesment

(ShareCast News) - Science and technology development company Allied Minds reported a wider loss in 2015 in its annual report on Monday, which it blamed on an increase in its investment in research and development and the creation of four new businesses during the year. The FTSE 250 firm posted a ne

Read more
25 Apr 2016 06:25

TOP NEWS: Allied Minds Loss Widens As It Invests In New Businesses

Read more
18 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
16 Mar 2016 08:36

LONDON MARKET OPEN: Commodity Stocks Take Back Losses But Hikma Falls

Read more
16 Mar 2016 08:08

Allied Minds forms cancer drug arm with NYU School of Medicine

(ShareCast News) - Allied Minds has launched a new subsidiary to develop potential cancer drugs from compounds developed by the New York University School of Medicine. Allied's joint venture with pharma group Bristol-Myers Squibb, Allied-Bristol Life Sciences, has set up the subsidiary, called ißeCa

Read more
16 Mar 2016 07:36

Allied Minds Joint Venture Signs Deal With New York University

Read more
9 Feb 2016 14:47

FTSE 250 movers: Redrow falls despite rise in profits

(ShareCast News) - The FTSE 250 continued to slide on Tuesday, with the second tier market down 140.79 points (0.91%) to 15,357.20 by mid-afternoon. Redrow was near the top of the fallers list despite posting a rise in first half pre-tax profit as revenue and completions grew. In the six months to

Read more
9 Feb 2016 10:42

WINNERS & LOSERS SUMMARY: Bond Disclosure Sends Legal & General Higher

Read more
9 Feb 2016 09:08

UPDATE: Allied Minds Hit By Revenue Drop From RF Biocidics Shortfall

Read more
9 Feb 2016 07:59

Allied Minds Eyes Commercialisation Opportunities In 2016

Read more
9 Feb 2016 07:32

Allied Minds marks 2015 as year of investment

(ShareCast News) - Allied Minds laid out 2015 as a year of investment, rather than cashflow, as it updated the market on Tuesday of its trading in the 12 months to 31 December 2015. The company had net cash and investments - including cash in the form of fixed income securities - of $194.8m (£135.37

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.